The WHO's approval of the AIIMS-developed mRNA cancer therapy marks a significant milestone for Indian medical research, with clinical trials showing a 94% success rate across 17 cancer types.
How the Therapy Works
The personalized mRNA treatment is tailored to each patient's specific tumor profile, training the immune system to target cancer cells while sparing healthy tissue — a significant advance over traditional chemotherapy's broader side-effect profile.
WHO officials say the approval paves the way for wider rollout across public hospitals in low- and middle-income countries within the next two years.
#Health#Cancer#AIIMS
